FLAG-empty FLAG-PPP2R2A FLAG-PPP2R5C FLAG-empty FLAG-PPP2R2A FLAG-PPP2R5C FLAG-empty FLAG-PPP2R2A FLAG-PPP2R5C FLAG-empty FLAG-PPP2R2A FLAG-PPP2R5C Isolation of complete PP2A holoenzymes was confirmed by western blot analysis (right panels). (B) Phosphatase activity against the pT481 site on PRC1 was measured by incubating recombinant PRC1-pT481 purified from insect cells with a set amount of whole cell lysate and increasing amounts of purified PP2A-B55α holoenzyme. From this experiment it was estimated that 0.25x PPP2R2A gave the same specific activity as 1x lysate. (C) Purified holoenzyme fractions were diluted (37 fold) and the indicated volumes loaded per lane. Titration demonstrates PP2A-B55α was 1.5x more concentrated than PP2A-B56γ. As such, PP2A-B55α was diluted 1.5 fold before use in assays described in Figure 3 . (D) Following the assay described in Figure 3A , 0 min samples for each condition were blotted for PP2A catalytic and scaffold subunits. Blots confirmed the required amount of each matched holoenzyme had been added to the assay relative to lysate. (A) Cells were lysed at 1.0 mg/ml and incubated on ice for 1 hour in the presence or absence of okadaic acid. Mass spectrometry of ENSA from these okadaic acid treated or control cell lysates was performed as described previously (Zeng et al., 2010) . (B) Blots confirming siRNA depletion for experiments described in Figure 4B . Samples from the 60 min +okadaic acid condition were blotted. Results confirm efficient siRNA depletion and demonstrate that for each condition cells start off with the same amount of pT481 phosphorylation on PRC1. (C) Samples from Figure 4B were probed for total PRC1 to confirm even protein loading. (D) ENSA phosphorylation was analysed using Phos-Tag in cells depleted of Greatwall/MASTL, ENSA, or ARPP19, lysed at 1 mg/ml and then incubated on ice for 1 hour in the presence or absence of okadaic acid. (E) Western blotting was performed using 0.5-15.0 ng recombinant His-tagged ARPP19 to determine the sensitivity of the antibody. Samples containing 15 µg protein from the 60 min +okadaic acid condition described in Figure 4B were western blotted alongside 5.0 ng His-tagged ARPP19. There was no detectable ARPP19 signal in these samples, suggesting ARPP19 is at a level <0.03 ng/µg cellular protein when it would need to be at ~1 ng/µg cell extract to be equimolar with PP2A-B55. (Shindo et al., 2012) . Separase inhibition of Cdk1-cyclin B is also lost, and results in an ~10 min shift in PP2A-B55 activity to later times, thus delaying activation of the anaphase spindle elongation protein PRC1. Simulation of mitotic exit with SA-separase was performed with a model in which all anaphase inhibitor (Ana I) containing dynamic variables were separated into two ODE's in order to distinguish the temporal behaviour of cyclin B and securin. 
Supplemental experimental procedures

Reagents and antibodies
Antibodies used are listed in the Key: Rb = Rabbit; Sh = Sheep; Mo = Mouse; Go = Goat.
Antibodies to ENSA and ARPP19 were produced against full-length recombinant protein antigen. Specific antibodies were purified using antigen conjugated to Affigel-15, eluted with 0.2M glycine pH 2.8, then dialyzed against PBS before storage at -80°C. Antibodies to PRC1, PRC1 pT602, and Plk1 were described previously Neef et al., 2007; Neef et al., 2003) . Affinity purified primary and HRP-coupled secondary antibodies (Jackson ImmunoResearch Laboratories, Inc) were used at 1µg/ml final concentration. All western blots were revealed using ECL (GE Healthcare).
General laboratory chemicals and reagents were obtained from Sigma- 
Protein expression and purification
Recombinant baculoviruses encoding hexahistidine-tagged PRC1 or Plk1 were used to infect 4x10 were concentrated using Ultracel -10K centrifugal filters (Millipore) to a final volume of 1ml. Samples were buffer exchanged into 20mM Tris-HCl pH 8.0, 300mM NaCl and 1mM DTT using 5ml Zeba desalt spin columns (Perbio).
Purified protein was snap frozen in 15µl aliquots and stored at -80°C. To generate the PRC1-pT602 substrate lacking pT481 phosphorylation, 158µg
PRC1 purified from insect cells that had not been treated with okadaic acid or nocodazole was phosphorylated in vitro by incubating with 300µg Plk1 in a final volume of 500µl 20mM Tris-HCl pH 8.0, 300mM NaCl, 1mM DTT, 3mM
Mg-ATP for 3h at 21°C. This sample was further purified by gel filtration on a Superose 6 10/300 column at 0.2ml/min and the fractions containing PRC1-pT602, confirmed by western blotting, snap frozen and stored at -80°C.
Mitotic extract preparation and ion-exchange chromatography
Twenty 15cm dishes (500,000 Hela S3 cells per plate) were grown for 72h
prior to 18h treatment with 100ng/ml nocodazole. Mitotic cells isolated by shake off were washed in ice cold PBS (3x50ml) and then lysed on ice for Activity assays with purified PP2A holoenzymes PPP2R2A holoenzymes purified as described in the online supplemental material were matched to lysate generated in the chromatography experiment by titration to yield the same relative activity against PRC1 pT481. Reactions were setup on ice and performed in tubes treated with a blocking buffer flavopiridol and 1µM BI2536). Activity in 110µg of mitotic lysate was tested alongside increasing amounts of PPP2R2A holoenzyme: 540ng (0.16x), 970ng (0.3x) and 1300ng (0.4x)). From this titration it was estimated that 810ng (0.25x) gave a relative activity that matched the lysate condition.
Western blotting of catalytic and scaffold subunits revealed that the concentration of isolated PPP2R5C holoenzymes was 1.5x less than PPP2R2A; as such, PPP2R2A was diluted 1.5 fold in elution buffer containing 25% [vol/vol] glycerol and 1mM DTT to bring holoenzymes to the same concentration. Assays were then performed using 100µg lysate or 770ng of each holoenzyme against either 380ng PRC1-pT481/pT602 or 90ng PRC1-pT602 (equivalent to a matched amount of pT602) in 175µl reaction buffer supplemented where appropriate with 100nM okadaic acid. Recombinant PRC1 and mitotic cell extract were prepared as described in the supplemental online material. An equal volume of undiluted eluate from the pCDNA5-Flag (empty vector) control IP was used in mock reactions to ensure that nonspecific phosphatase activity was not associated with the beads. For both titration and assay experiments samples were removed at indicated time points, added to SDS-sample buffer and boiled immediately for 5min to stop reactions.
Live and fixed cell microscopy
Fixed cell microscopy was carried out exactly as described previously (Dunsch et al., 2012) . which is the protease responsible for cohesin cleavage and anaphase initiation. We assume that cyclin B is a constant fraction of Ana I (the fraction is represented with the parameter ε) and that cyclinB is in complex with Cdk1.
For some experiments the model was supplemented with a constant level (zero during normal mitotic exit) of non-degradable cyclin B that can bind to and inhibit separase (Eq. 7). When Cdk1-cyclin B is not associated with APC or separase, it is able to phosphorylate its substrates Greatwall/MASTL and PRC1. Both of these substrates are dephosphorylated by PP2A-B55. Cdk1-cyclin B phosphorylates Greatwall/MASTL (Eq. 8), and then this active Gwl in turn phosphorylates ENSA to convert it to a PP2A-B55 inhibitor (Eq. 9). The phosphorylated ENSA (ENSA-P) binds reversibly to PP2A-B55 (Eq. 10) and thereby blocks Gwl and PRC1 T481 dephosphorylation by PP2A-B55.
Dephosphorylation of ENSA-P might be catalysed by PP2A-B55 or by another phosphatase, and we assume PP2A-B55 is not essential for ENSA dephosphorylation.
PRC1 is phosphorylated at two sites (T481 and T602), which could define four species with different phosphorylation states. Cdk1-cyclin B and
Polo-kinase are responsible for T481 and T602 phosphorylation, respectively (Eq. 11 & 12) . Dephosphorylation of T481 is catalysed by PP2A-B55 while phosphorylated T602 is targeted by PP2A-B56. According to our experimental data, T481 phosphorylation promotes T602 dephosphorylation. This allows us to neglect the double-phosphorylated form in the model (see Suppl. Fig. S4 ).
The conservation relationship, that the total level of a protein is the sum of all its forms, allows us to calculate the free (not in complex) forms of APC, Ana I, separase and PP2A-B55 (Eq. 13-16). The same conservation relationship also allows us to calculate the unphosphorylated form of PRC1 by subtracting the phosphorylated ones from the constant total level (Eq. 17). Cdk1-cyclin B inhibition by flavopiridol (FLA) is described by Eq. 18.
Mitotic exit which is a short window of the cell cycle, and we assume that APC, separase, PP2A-B55 and PRC1 levels are constant during this time window. Therefore the total levels of these proteins are described with constant parameters. kpGW=100, kdpGW_bk=0, kdpGW_B55=50, kpE=8, kdpE=5, kp481=10, kdp481=0.5, kp602=2, kdp602=1.
Model parameters
